TBCA

• Supplier: Tocris Bioscience
• Catalog: 2275
• Prices: $179.00
• Sizes: 10 mg
• Function Type: Inhibitor
• Cas Number: 934358-00-6
• Chemical Name: (2E)-3-(2,3,4,5-Tetrabromophenyl)-2-propenoicacid
• Formula: C9H4Br4O2
• Molecular Weight: 463.74
• Purity: >98 %
• Description: Selective CK2 inhibitor (IC 50 = 110 nM). Exhibits selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases. Reduces viability of Jurkat cells in vitro .

Product References

DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid - DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid

Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, Nakajima T. Mol Pharmacol. 1998 Feb;53(2):195-201.

Inhibition of uptake unmasks rapid extracellular turnover of glutamate of - Inhibition of uptake unmasks rapid extracellular turnover of glutamate of

Jabaudon D, Shimamoto K, Yasuda-Kamatani Y, Scanziani M, Gahwiler BH, Gerber U. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8733-8.

Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate - Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate

Shimamoto K, Shigeri Y, Yasuda-Kamatani Y, Lebrun B, Yumoto N, Nakajima T. Bioorg Med Chem Lett. 2000 Nov 6;10(21):2407-10.

Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid - Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid

Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, Seal RP, Yumoto N, Nakajima T, Amara SG. J Neurochem. 2001 Oct;79(2):297-302.